vs

Side-by-side financial comparison of Globalstar, Inc. (GSAT) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $72.0M, roughly 1.2× Globalstar, Inc.). Globalstar, Inc. runs the higher net margin — -16.1% vs -38.1%, a 21.9% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 17.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 12.9%).

Globalstar, Inc. is an American telecommunications company that operates a satellite constellation in low Earth orbit (LEO) for satellite phone, low-speed data transmission and Earth observation. The Globalstar second-generation constellation consists of 25 satellites.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

GSAT vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.2× larger
PRCT
$83.1M
$72.0M
GSAT
Growing faster (revenue YoY)
PRCT
PRCT
+2.6% gap
PRCT
20.2%
17.6%
GSAT
Higher net margin
GSAT
GSAT
21.9% more per $
GSAT
-16.1%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
12.9%
GSAT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
GSAT
GSAT
PRCT
PRCT
Revenue
$72.0M
$83.1M
Net Profit
$-11.6M
$-31.6M
Gross Margin
64.9%
Operating Margin
-0.5%
-4.1%
Net Margin
-16.1%
-38.1%
Revenue YoY
17.6%
20.2%
Net Profit YoY
76.9%
-27.9%
EPS (diluted)
$-0.11
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GSAT
GSAT
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$72.0M
$76.4M
Q3 25
$73.8M
$83.3M
Q2 25
$67.1M
$79.2M
Q1 25
$60.0M
$69.2M
Q4 24
$61.2M
$68.2M
Q3 24
$72.3M
$58.4M
Q2 24
$60.4M
$53.4M
Net Profit
GSAT
GSAT
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-11.6M
$-29.8M
Q3 25
$1.1M
$-21.4M
Q2 25
$19.2M
$-19.6M
Q1 25
$-17.3M
$-24.7M
Q4 24
$-50.2M
$-18.9M
Q3 24
$9.9M
$-21.0M
Q2 24
$-9.7M
$-25.6M
Gross Margin
GSAT
GSAT
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
GSAT
GSAT
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-0.5%
-40.6%
Q3 25
13.8%
-27.8%
Q2 25
9.2%
-28.0%
Q1 25
-14.2%
-39.7%
Q4 24
-6.9%
-28.9%
Q3 24
13.0%
-38.4%
Q2 24
-2.4%
-50.3%
Net Margin
GSAT
GSAT
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-16.1%
-39.1%
Q3 25
1.5%
-25.7%
Q2 25
28.6%
-24.7%
Q1 25
-28.9%
-35.8%
Q4 24
-82.1%
-27.6%
Q3 24
13.7%
-35.9%
Q2 24
-16.0%
-48.0%
EPS (diluted)
GSAT
GSAT
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.11
$-0.54
Q3 25
$-0.01
$-0.38
Q2 25
$0.13
$-0.35
Q1 25
$-0.16
$-0.45
Q4 24
$-0.57
$-0.34
Q3 24
$0.00
$-0.40
Q2 24
$-0.01
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GSAT
GSAT
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$447.5M
$245.6M
Total DebtLower is stronger
$483.8M
$51.7M
Stockholders' EquityBook value
$355.7M
$347.7M
Total Assets
$2.3B
$487.1M
Debt / EquityLower = less leverage
1.36×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GSAT
GSAT
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$447.5M
$286.5M
Q3 25
$346.3M
$294.3M
Q2 25
$308.2M
$302.7M
Q1 25
$241.4M
$316.2M
Q4 24
$391.2M
$333.7M
Q3 24
$51.9M
$196.8M
Q2 24
$64.3M
$214.1M
Total Debt
GSAT
GSAT
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$483.8M
$51.6M
Q3 25
$508.6M
$51.6M
Q2 25
$491.5M
$51.5M
Q1 25
$502.7M
$51.5M
Q4 24
$511.4M
$51.5M
Q3 24
$394.4M
$51.4M
Q2 24
$393.1M
$51.4M
Stockholders' Equity
GSAT
GSAT
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$355.7M
$365.9M
Q3 25
$364.8M
$380.3M
Q2 25
$360.9M
$385.8M
Q1 25
$344.3M
$389.2M
Q4 24
$358.9M
$402.2M
Q3 24
$394.1M
$241.2M
Q2 24
$383.0M
$251.8M
Total Assets
GSAT
GSAT
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$2.3B
$508.1M
Q3 25
$2.2B
$511.5M
Q2 25
$1.9B
$513.1M
Q1 25
$1.7B
$519.4M
Q4 24
$1.7B
$534.0M
Q3 24
$917.6M
$374.1M
Q2 24
$926.2M
$374.4M
Debt / Equity
GSAT
GSAT
PRCT
PRCT
Q1 26
0.15×
Q4 25
1.36×
0.14×
Q3 25
1.39×
0.14×
Q2 25
1.36×
0.13×
Q1 25
1.46×
0.13×
Q4 24
1.43×
0.13×
Q3 24
1.00×
0.21×
Q2 24
1.03×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GSAT
GSAT
PRCT
PRCT
Operating Cash FlowLast quarter
$175.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GSAT
GSAT
PRCT
PRCT
Q1 26
Q4 25
$175.9M
$-10.3M
Q3 25
$236.0M
$-6.6M
Q2 25
$157.9M
$-15.0M
Q1 25
$51.9M
$-17.0M
Q4 24
$340.7M
$-32.4M
Q3 24
$32.0M
$-18.8M
Q2 24
$36.7M
$-15.7M
Free Cash Flow
GSAT
GSAT
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
GSAT
GSAT
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
GSAT
GSAT
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
GSAT
GSAT
PRCT
PRCT
Q1 26
Q4 25
Q3 25
216.53×
Q2 25
8.22×
Q1 25
Q4 24
Q3 24
3.23×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GSAT
GSAT

Services$67.4M94%
Products$4.6M6%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons